Arabian International Healthcare Holding Co. (Tibbiyah) reported a net loss after Zakat and tax of SAR 20.7 million for the first half of 2022, against a profit of SAR 5.1 million in the same period a year earlier.
Item | 6m 2021 | 6m 2022 | Change |
---|---|---|---|
Revenues | 249.24 | 215.24 | (13.6 %) |
Gross Income | 57.73 | 40.80 | (29.3 %) |
Operating Income | 9.40 | (16.92) | (280.1 %) |
Net Income | 5.10 | (20.68) | (505.8 %) |
Average Shares | 20.00 | 20.00 | - |
EPS (Riyals) | 0.25 | (1.03) | (505.8 %) |
The losses were attributed to delayed sales in H1 2022 due to global supply chain disruptions and higher profitability due to COVID-19-related sales in H1 2021, in addition to investment in human capital to support the company’s ambitious growth strategy.
Item | H1 2021 | H1 2022 | Change |
---|---|---|---|
Revenues | 249.24 | 215.24 | (13.6 %) |
Gross Income | 57.73 | 40.80 | (29.3 %) |
Operating Income | 9.40 | (16.92) | (280.1 %) |
Net Income | 5.10 | (20.68) | (505.8 %) |
Average Shares | 20.00 | 20.00 | - |
EPS (Riyals) | 0.25 | (1.03) | (505.8 %) |
Item | H2 2021 | H1 2022 | Change |
---|---|---|---|
Revenues | 369.30 | 215.24 | (41.7 %) |
Gross Income | 85.79 | 40.80 | (52.4 %) |
Operating Income | 60.70 | (16.92) | (127.9 %) |
Net Income | 77.22 | (20.68) | (126.8 %) |
Average Shares | 20.00 | 20.00 | - |
EPS (Riyals) | 3.86 | (1.03) | (126.8 %) |
Total shareholders’ equity (after excluding minority interest) stood at SAR 252.711 million as of June 30, 2022, compared to SAR 254.858 million a year earlier.
Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
---|---|---|---|---|---|---|
H1 2013 | - | - | - | - | - | - |
H2 2013 | - | - | - | - | - | - |
2013 | - | - | - | - | - | - |
H1 2014 | - | - | - | - | - | - |
H2 2014 | - | - | - | - | - | - |
2014 | - | - | - | - | - | - |
H1 2015 | - | - | - | - | - | - |
H2 2015 | - | - | - | - | - | - |
2015 | - | - | - | - | - | - |
H1 2016 | - | - | - | - | - | - |
H2 2016 | - | - | - | - | - | - |
2016 | - | - | - | - | - | - |
H1 2017 | - | - | - | - | - | - |
H2 2017 | - | - | - | - | - | - |
2017 | - | - | - | - | - | - |
H1 2018 | - | - | - | - | - | - |
H2 2018 | - | - | - | - | - | - |
2018 | - | - | - | - | - | - |
H1 2019 | - | - | - | - | - | - |
H2 2019 | - | - | - | - | - | - |
2019 | 697.03 | - | 171.34 | - | 61.71 | - |
H1 2020 | 193.65 | - | 38.94 | - | (10.98) | - |
H2 2020 | 625.04 | - | 159.44 | - | 109.27 | - |
2020 | 818.69 | 17.5 % | 198.38 | 15.8 % | 98.28 | 59.3 % |
H1 2021 | 249.24 | 28.7 % | 57.73 | 48.2 % | 9.40 | 185.5 % |
H2 2021 | 369.30 | (40.9 %) | 85.79 | (46.2 %) | 60.70 | (44.4 %) |
2021 | 618.54 | (24.4 %) | 143.52 | (27.7 %) | 70.10 | (28.7 %) |
H1 2022 | 215.24 | (13.6 %) | 40.80 | (29.3 %) | (16.92) | (280.1 %) |
Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
---|---|---|---|---|---|---|
2012 | - | - | - | - | - | - |
2013 | - | - | - | - | - | - |
2014 | - | - | - | - | - | - |
2015 | - | - | - | - | - | - |
2016 | - | - | - | - | - | - |
2017 | - | - | - | - | - | - |
2018 | - | - | - | - | - | - |
2019 | 697.03 | - | 171.34 | - | 61.71 | - |
2020 | 818.69 | 17.5 % | 198.38 | 15.8 % | 98.28 | 59.3 % |
2021 | 618.54 | (24.4 %) | 143.52 | (27.7 %) | 70.10 | (28.7 %) |
Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
---|---|---|---|---|---|---|
H1 2013 | - | - | - | - | - | - |
H2 2013 | - | - | - | - | - | - |
2013 | - | - | - | - | - | - |
H1 2014 | - | - | - | - | - | - |
H2 2014 | - | - | - | - | - | - |
2014 | - | - | - | - | - | - |
H1 2015 | - | - | - | - | - | - |
H2 2015 | - | - | - | - | - | - |
2015 | - | - | - | - | - | - |
H1 2016 | - | - | - | - | - | - |
H2 2016 | - | - | - | - | - | - |
2016 | - | - | - | - | - | - |
H1 2017 | - | - | - | - | - | - |
H2 2017 | - | - | - | - | - | - |
2017 | - | - | - | - | - | - |
H1 2018 | - | - | - | - | - | - |
H2 2018 | - | - | - | - | - | - |
2018 | - | - | - | - | - | - |
H1 2019 | - | - | - | - | - | - |
H2 2019 | - | - | - | - | - | - |
2019 | 41.13 | - | 2.06 | (7.00) | 48.13 | 2.41 |
H1 2020 | (30.96) | - | (1.55) | - | (30.96) | (1.55) |
H2 2020 | 126.75 | - | 6.34 | 36.37 | 90.37 | 4.52 |
2020 | 95.79 | 132.9 % | 4.79 | 36.37 | 59.42 | 2.97 |
H1 2021 | 5.10 | 116.5 % | 0.25 | - | 5.10 | 0.25 |
H2 2021 | 77.22 | (39.1 %) | 3.86 | 14.63 | 62.59 | 3.13 |
2021 | 82.31 | (14.1 %) | 4.12 | 14.63 | 67.69 | 3.38 |
H1 2022 | (20.68) | (505.8 %) | (1.03) | - | (20.68) | (1.03) |
Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
---|---|---|---|---|---|---|
2012 | - | - | - | - | - | - |
2013 | - | - | - | - | - | - |
2014 | - | - | - | - | - | - |
2015 | - | - | - | - | - | - |
2016 | - | - | - | - | - | - |
2017 | - | - | - | - | - | - |
2018 | - | - | - | - | - | - |
2019 | 41.13 | - | 2.06 | (7.00) | 48.13 | 2.41 |
2020 | 95.79 | 132.9 % | 4.79 | 36.37 | 59.42 | 2.97 |
2021 | 82.31 | (14.1 %) | 4.12 | 14.63 | 67.69 | 3.38 |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
H1 2013 | - | - | - |
H2 2013 | - | - | - |
2013 | - | - | - |
H1 2014 | - | - | - |
H2 2014 | - | - | - |
2014 | - | - | - |
H1 2015 | - | - | - |
H2 2015 | - | - | - |
2015 | - | - | - |
H1 2016 | - | - | - |
H2 2016 | - | - | - |
2016 | - | - | - |
H1 2017 | - | - | - |
H2 2017 | - | - | - |
2017 | - | - | - |
H1 2018 | - | - | - |
H2 2018 | - | - | - |
2018 | - | - | - |
H1 2019 | - | - | - |
H2 2019 | - | - | - |
2019 | 24.58 % | 9.88 % | 6.90 % |
H1 2020 | - | - | - |
H2 2020 | 24.23 % | 12.88 % | 7.26 % |
2020 | 24.23 % | 12.88 % | 7.26 % |
H1 2021 | 24.84 % | 14.38 % | 10.92 % |
H2 2021 | 23.20 % | 12.41 % | 10.94 % |
2021 | 23.20 % | 12.41 % | 10.94 % |
H1 2022 | 21.66 % | 8.60 % | 7.17 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
2012 | - | - | - |
2013 | - | - | - |
2014 | - | - | - |
2015 | - | - | - |
2016 | - | - | - |
2017 | - | - | - |
2018 | - | - | - |
2019 | 24.58 % | 9.88 % | 6.90 % |
2020 | 24.23 % | 12.88 % | 7.26 % |
2021 | 23.20 % | 12.41 % | 10.94 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
H1 2013 | - | - | - |
H2 2013 | - | - | - |
H1 2014 | - | - | - |
H2 2014 | - | - | - |
H1 2015 | - | - | - |
H2 2015 | - | - | - |
H1 2016 | - | - | - |
H2 2016 | - | - | - |
H1 2017 | - | - | - |
H2 2017 | - | - | - |
H1 2018 | - | - | - |
H2 2018 | - | - | - |
H1 2019 | - | - | - |
H2 2019 | - | - | - |
H1 2020 | 20.11 % | (3.78 %) | (15.99 %) |
H2 2020 | 25.51 % | 18.05 % | 14.46 % |
H1 2021 | 23.16 % | 5.19 % | 2.04 % |
H2 2021 | 23.23 % | 17.27 % | 16.95 % |
H1 2022 | 18.96 % | (6.29 %) | (9.61 %) |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
H1 2013 | - | - | - | - |
H2 2013 | - | - | - | - |
H1 2014 | - | - | - | - |
H2 2014 | - | - | - | - |
H1 2015 | - | - | - | - |
H2 2015 | - | - | - | - |
H1 2016 | - | - | - | - |
H2 2016 | - | - | - | - |
H1 2017 | - | - | - | - |
H2 2017 | - | - | - | - |
H1 2018 | - | - | - | - |
H2 2018 | - | - | - | - |
H1 2019 | - | - | - | - |
H2 2019 | - | - | - | - |
H1 2020 | 20.00 | - | - | - |
H2 2020 | 20.00 | 4.79 | 2.97 | 16.62 |
H1 2021 | 20.00 | 6.59 | 4.77 | 12.74 |
H2 2021 | 20.00 | 4.12 | 3.38 | 16.67 |
H1 2022 | 20.00 | 2.83 | 2.10 | 12.64 |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
2012 | - | - | - | - |
2013 | - | - | - | - |
2014 | - | - | - | - |
2015 | - | - | - | - |
2016 | - | - | - | - |
2017 | - | - | - | - |
2018 | - | - | - | - |
2019 | 20.00 | 2.06 | 2.41 | 13.31 |
2020 | 20.00 | 4.79 | 2.97 | 16.62 |
2021 | 20.00 | 4.12 | 3.38 | 16.67 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
H1 2013 | - | - | - |
H2 2013 | - | - | - |
H1 2014 | - | - | - |
H2 2014 | - | - | - |
H1 2015 | - | - | - |
H2 2015 | - | - | - |
H1 2016 | - | - | - |
H2 2016 | - | - | - |
H1 2017 | - | - | - |
H2 2017 | - | - | - |
H1 2018 | - | - | - |
H2 2018 | - | - | - |
H1 2019 | - | - | - |
H2 2019 | - | - | - |
H1 2020 | - | - | - |
H2 2020 | - | - | - |
H1 2021 | - | - | - |
H2 2021 | - | - | - |
H1 2022 | 18.43 | 24.86 | 4.12 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
2012 | - | - | - |
2013 | - | - | - |
2014 | - | - | - |
2015 | - | - | - |
2016 | - | - | - |
2017 | - | - | - |
2018 | - | - | - |
2019 | - | - | - |
2020 | - | - | - |
2021 | - | - | - |
Q2 2022
2022
Period | Medical devices | Medical supplies | Other activities |
---|---|---|---|
Q2 2021 | 123.93 | 125.30 | - |
Q4 2021 | 180.28 | 189.03 | - |
Q2 2022 | 73.94 | 141.30 | - |
Period | Medical devices | Medical supplies | Other activities |
---|---|---|---|
2019 | 416.44 | 280.60 | - |
2020 | 534.57 | 284.12 | - |
2021 | 304.21 | 314.33 | - |
Current | |
Market Cap (M Riyal) | 770.00 |
Enterprise Value (EV) (M) | 1,211.97 |
Shares Outstanding ((M)) | 20.00 |
Book Value (BV) ( Riyal) | 15.33 |
Par Value ( Riyal) | 10.00 |
Adjusted P/E (Last12) | More than 100 |
Price/book | 2.51 |
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}